1-5 of 5
Akira Kawasaki
Close
Sort by
Journal Articles

Real-World Evidence for the Safety and Effectiveness of Tirabrutinib in 140 Japanese Patients with Recurrent or Refractory Primary Central Nervous System Lymphoma: Interim Report of Postmarketing Surveillance

Akira Kawasaki, Masaru Matsushita, Shingo Yoshida, Tanomu Matsukura, Koji Izutsu, Ryo Nishikawa
Journal: Blood
Blood (2022) 140 (Supplement 1): 6685–6686.
https://doi.org/10.1182/blood-2022-156472
Published: 2022
Journal Articles

Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells

Zahra Kabiri, Akihiko Numata, Akira Kawasaki, Edison, Daniel G. Tenen, David M. Virshup
Journal: Blood
Blood (2015) 126 (9): 1086–1094.
https://doi.org/10.1182/blood-2014-09-598540
Published: 2015
Includes: Supplemental data
Journal Articles

Overexpression of Sharp-1 in MLL-AF6-Positive Acute Myeloid Leukemia

Akira Kawasaki, MD, PhD, Reshma Taneja, Ruud Delwel, PhD, Daniel G. Tenen, MD
Journal: Blood
Blood (2012) 120 (21): 3493.
https://doi.org/10.1182/blood.V120.21.3493.3493
Published: 2012
Journal Articles

Opposing effects of PML and PML/RARα on STAT3 activity

Akira Kawasaki, Itaru Matsumura, Yoshihisa Kataoka, Eri Takigawa, Koichi Nakajima, Yuzuru Kanakura
Journal: Blood
Blood (2003) 101 (9): 3668–3673.
https://doi.org/10.1182/blood-2002-08-2474
Published: 2003
Journal Articles

Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines

Itaru Matsumura, Akira Kawasaki, Hirokazu Tanaka, Junko Sonoyama, Sachiko Ezoe, Naoko Minegishi, Koichi Nakajima, Masayuki Yamamoto, Yuzuru Kanakura
Journal: Blood
Blood (2000) 96 (7): 2440–2450.
https://doi.org/10.1182/blood.V96.7.2440
Published: 2000